Details for 2016831788

Up to date per 01.04.2026

Actions

Title / Product Name

ANTIKÖRPERMOLEKÜLE GEGEN PD-1 UND VERWENDUNGEN DAVON

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016831788

EP Publication Number

3389712

E-Number

1674227

Language

PCT Number

US16067200

Publication Date

24.10.2018 A

10.04.2024 B1

Registration Date

10.04.2024

AT Publication Date

15.04.2024

Application Date

16.12.2016

Registration Number

Priorities

17.12.2015

201562269044 P

03.05.2016

201662331371 P

02.06.2016

201662344784 P

08.06.2016

201662347331 P

08.07.2016

201662359781 P

30.08.2016

201662381384 P

28.09.2016

201662400787 P

28.10.2016

201662414128 P

09.12.2016

201662431846 P

IPC

A61K 45/06 20060101AFI20231005BHEP

Maximum Duration of Protection

16.12.2036

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT

Inventor

BILIC, Sanela4711 153rd Ct Urbandale, IA 50323US

HOWARD, Danny, Roland, Jr.c/o Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, NJ 07936-1080US

CAMERON, John, Scottc/o Novartis Institutes for Biomedical Research, Inc. 250 Massachusetts Avenue Cambridge, MA 02139US

DRANOFF, Glennc/o Novartis Institutes for Biomedical Research, Inc. 250 Massachusetts Avenue Cambridge, MA 02139US

Information about Fees